oncology
News
A phase 3 trial of the mRNA vaccine, which has shown promising results in reducing cancer recurrence by almost half, is now underway in the UK.
News
Women under 50 diagnosed with breast cancer face an 86% higher risk for a second, new cancer compared with their peers in the general population.